Saimu Bioworks accelerates discovery for AI-driven biotech startups and big pharma — from target identification to clinical pipeline optimization.
What we do
We bridge the gap between AI-driven hypotheses and wet-lab validation, so your pipeline moves faster and smarter.
AI-assisted identification and biological validation of novel drug targets across oncology, rare disease, and CNS.
Custom assay pipelines optimized for your AI model outputs — from HTS to phenotypic screening and functional readouts.
High-quality, ML-ready biological datasets to train, fine-tune, and validate your AI models with confidence.
Integrated CRO support and scientific project management to compress your preclinical timelines without compromising rigor.
Scientific advisory and IND-enabling support to bridge your AI-predicted candidates to clinical-stage readiness.
Bridging computational predictions with experimental reality — we help your models learn from biology, not just predict it.
Why Us
Reach your study goals with highly precise and reproducible CNS drug delivery using advanced stereotaxic robotic systems and a full spectrum of systemic drug administration methods.
Generate robust preclinical in vivo data with our comprehensive service portfolio, including motor, cognitive, and social behavior studies, in vivo imaging, ophthalmology, and electrophysiological analysis.
Get in touch
Tell us about your project and we'll be in touch within 24 hours.
Address:
Saimu Bioworks Pvt Ltd
801 Capitola Drive, Ste. 12 Durham NC 27713
Email:
info@saimubioworks.com
Phone:
+1 774 232 3001
Working Hours:
Monday – Friday
9:00 AM – 6:00 PM